BioSpace News Archive

Exelixis, Inc. announced that the company will be presenting at the following investor conferences in March

Synlogic, Inc. announced that the Company will release its fourth quarter and full year 2018 financial results before the market opens on Tuesday, March 12, 2019.

Ligand Pharmaceuticals Incorporated and Royalty Pharma announce the sale of Ligand’s Promacta®-related intellectual property rights licensed to Novartis, including the royalty stream on worldwide net sales of Promacta to Royalty Pharma for $827 million in cash.

The AmerisourceBergen Foundatio has committed $25,000 to support relief efforts in communities affected by the tornadoes that recently swept through the Southeast United States.

Ended 2018 with four molecules in clinical development, including AB928, the Company’s dual A2aR/A2bR receptor antagonist, which is being evaluated in several dose-escalation trials in combination with chemotherapy or AB122 (anti-PD-1 antibody)

Puma Biotechnology, Inc., a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 10:00 a.m. EDT on Tuesday, March 12 at the Cowen and Company 39th Annual Health Care Conference.

Gilead Sciences, Inc. announced that Robin L. Washington, Gilead’s Executive Vice President and Chief Financial Officer and John McHutchison, AO, MD, Gilead’s Chief Scientific Officer and Head of Research & Development, will participate in a fireside chat at the Barclays Global Healthcare Conference in Miami on Tuesday, March 12 at 10:45 a.m. Eastern Time.

Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that management will present at the Cowen 39th Annual Health Care Conference in Boston, MA on Tuesday, March 12, 2019 at 11:20 a.m., ET.

Gilead Sciences, Inc. announced that Alessandro Riva, MD, Executive Vice President, Oncology Therapeutics, has decided to leave the company to pursue another opportunity.

Current Board Member Tim Pearson to become Board Chair effective at the close of the company’s annual meeting on May 17, 2019